IRAK3 and type 2 diabetes mellitus: Experimental results indicated significantly elevated IRAK3 expression in the T2DM and MAFLD group compared to the control group, suggesting that IRAK3 may play a vital role in the pathophysiology of T2DM and MAFLD.